Candida auris US outbreak expansion

C. auris clinical cases reported in 23-27 states with over 3,437 cases in 2026. Texas leads with 715 cases. Resistance high (95% fluconazole, 1% pan-resistant). Mortality 30-60%. Rate of increase slowing but still a major threat in healthcare settings.